Moderna
MRNA
#1261
Rank
โ‚น1.200 T
Marketcap
โ‚น3,120
Share price
-0.94%
Change (1 day)
-52.57%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น1.200 Trillion

As of November 2024 Moderna has a market cap of โ‚น1.200 Trillion. This makes Moderna the world's 1261th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น1.200 T-61.96%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Moderna was reported to be:

โ‚น1.200 Trillion
by Yahoo Finance info icon info icon
โ‚น1.200 Trillion
by CompaniesMarketCap info icon info icon
โ‚น1.200 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น7.74 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.820 T 1,633.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น70.38 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.710 T 125.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น17.415 T 1,350.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น196.47 B-83.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.138 T 2,493.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น251.52 B-79.05%๐Ÿ‡บ๐Ÿ‡ธ USA